Novel embolic solutions for interventional radiology
NovaSeal™ - Our flagship product
NovaSeal™ is packaged as a ready-to-use product, eliminating the need for complex and time-consuming preparation steps in hospitals.
Unlike marketed products that rely on heavy metals like tantalum, which pose toxicity risks, NovaSeal™ provides a safer alternative. By avoiding toxic solvents and enhancing ease of use, NovaSeal™ significantly improves the experience for both patients and healthcare providers.
NovaSeal™ is a liquid embolic agent composed of a biocompatible polymer mixture and loaded with a contrast agent that transitions from a liquid to a gel state at body temperature. Packaged in a sterile syringe with a standard Luer lock tip, it is injected into a target vessel via intravascular catheters. Upon injection, NovaSeal™ forms a hydrogel embolus, creating a mechanical barrier that occludes blood flow.
Ongoing projects and clinical trials
We have completed the in vitro studies. Our team is now focused on designing the preclinical studies, which will pave the way for further verification of NovaSeal™'s safety and efficacy. Following this, we will lay the groundwork for first-in-human trials and prepare for our entry into the global market.
NovaSeal born
Proof of concept
Verification
Validation